Atlas Trials

Hummingbird Bioscience

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Hummingbird Bioscience

RecordFirmDate
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors (NCT06956690)Hummingbird Bioscience2025-12-17
A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers (NCT05910827)Hummingbird Bioscience2024-02-05
Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation (NCT05919537)Hummingbird Bioscience2023-09-06
A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors (NCT05082610)Hummingbird Bioscience2022-02-28

Track Hummingbird Bioscience automatically

Every clearance here is in the API, with alerts when new ones post.